scholarly journals Effects of Byakushi and Ogon extracts on rat hepatic drug metabolizing enzymes in vivo

1992 ◽  
Vol 58 ◽  
pp. 331
Author(s):  
Makoto Mayanagi ◽  
Sadao Nakayama ◽  
Katsuji Qguchi
2011 ◽  
Vol 63 (3) ◽  
pp. 545-555 ◽  
Author(s):  
Sevki Arslan ◽  
Ozden Ozgun ◽  
Gurbet Celik ◽  
Asli Semiz ◽  
Olcay Dusen ◽  
...  

The modulatory effects of the Cyclamen trochopterantum tuber extract on hepatic drug-metabolizing enzymes, including aniline 4-hydroxylase (A4H; CYP2E1), ethoxyresorufin O-deethylase (EROD; CYP1A), methoxyresorufin O-demethylase (MROD; CYP1A), caffeine N-demethylase (C3ND; CYP1A2) aminopyrene N-demethylase (APND; CYP2C6), and erythromycin N-demethylase (ERND; CYP3A1), were examined in vivo in rats. The activities of all of these enzymes were induced by the cyclamen extract. In addition, Western-blot and RT-PCR results clearly showed that CYP2E1, CYP1A1/CYP1A2 and CYP2C6 protein and mRNA levels were substantially increased by four different doses of cyclamen. Although, the CYP3A1 protein level was increased significantly, the mRNA level was not changed. These results indicate that cyclamen tuber extract might have a potential not only to inhibit and/or induce the metabolism of certain co-administered drugs but also influence the development of toxicity and carcinogenesis due to the induction of the cytochrome P450-dependent drug-metabolizing enzymes.


2021 ◽  
Vol 22 (15) ◽  
pp. 7885
Author(s):  
Vladimír Křen

This review focuses on the specific biological effects of optically pure silymarin flavo-nolignans, mainly silybins A and B, isosilybins A and B, silychristins A and B, and their 2,3-dehydro derivatives. The chirality of these flavonolignans is also discussed in terms of their analysis, preparative separation and chemical reactions. We demonstrated the specific activities of the respective diastereomers of flavonolignans and also the enantiomers of their 2,3-dehydro derivatives in the 3D anisotropic systems typically represented by biological systems. In vivo, silymarin flavonolignans do not act as redox antioxidants, but they play a role as specific ligands of biological targets, according to the “lock-and-key” concept. Estrogenic, antidiabetic, anticancer, antiviral, and antiparasitic effects have been demonstrated in optically pure flavonolignans. Potential application of pure flavonolignans has also been shown in cardiovascular and neurological diseases. Inhibition of drug-metabolizing enzymes and modulation of multidrug resistance activity by these compounds are discussed in detail. The future of “silymarin applications” lies in the use of optically pure components that can be applied directly or used as valuable lead structures, and in the exploration of their true molecular effects.


1990 ◽  
Vol 39 (1) ◽  
pp. 212-216 ◽  
Author(s):  
Thananda Sukhumanan ◽  
Wichitra Suphakawanich ◽  
Amnuay Thithapandha

1980 ◽  
Vol 15 (6) ◽  
pp. 723-754 ◽  
Author(s):  
Ernest Hodgson ◽  
Arun P. Kulkarni ◽  
David L. Fabacher ◽  
Karen M. Robacker

2017 ◽  
Vol 5 (5) ◽  
pp. e00361 ◽  
Author(s):  
Kentaro Nobutani ◽  
Jun Miyoshi ◽  
Mark W. Musch ◽  
Mitsue Nishiyama ◽  
Junko Watanabe ◽  
...  

1975 ◽  
Vol 24 (7) ◽  
pp. 779-783 ◽  
Author(s):  
David R. Bickers ◽  
Julie Eiseman ◽  
Attallah Kappas ◽  
Alvito P. Alvares

Sign in / Sign up

Export Citation Format

Share Document